Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04880863 |
Title | Naptumomab Estafenatox (NAP) in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC (NT-NAP-102-1) |
Acronym | NT-NAP-102-1 |
Recruitment | Completed |
Gender | |
Phase | Phase II |
Variant Requirements | No |
Sponsors | NeoTX Therapeutics Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
NeoTX - 10307 | Daphne | Alabama | 36526 | United States | Details | |
NeoTX - 10302 | Scottsdale | Arizona | 85258 | United States | Details | |
NeoTX - 10303 | Tucson | Arizona | 85711 | United States | Details | |
NeoTX - 10306 | Lone Tree | Colorado | 80124 | United States | Details | |
NeoTX - 10304 | Minneapolis | Minnesota | 55404 | United States | Details | |
NeoTX - 10100 | Morristown | New Jersey | 07962 | United States | Details | |
NeoTX - 10308 | Austin | Texas | 78745 | United States | Details | |
NeoTX - 10309 | Dallas | Texas | 75246 | United States | Details | |
NeoTX - 10312 | El Paso | Texas | 79902 | United States | Details | |
NeoTX - 10310 | Tyler | Texas | 75702 | United States | Details | |
NeoTX - 10311 | Fairfax | Virginia | 22205 | United States | Details |